Skip to main content

Advertisement

SpringerLink
Log in

Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Antitumor necrosis alpha agents have been successfully used for the treatment of rheumatoid and seronegative arthritis, Crohn’s disease, psoriasis, and severe cases of vasculitis. Several side effects have been observed in patients receiving these agents including hypersensitivity reactions, infections, drug-induced lupus, or demyelinating syndromes. The presence of peripheral neuropathy has been reported only in isolated cases. We describe two cases of peripheral neuropathy which occurred in patients with rheumatoid arthritis receiving infliximab treatment, one with multifocal motor neuropathy with conduction block and another with axonal sensory polyneuropathy, reversed upon discontinuation of infliximab and intravenous gammaglobulin treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hyrich KL, Silman AJ, Watson KD, Symmons DP (2004) Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 63:1538–1543

    Article  PubMed  CAS  Google Scholar 

  2. Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism. By what mechanism could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44:1977–1983

    Article  PubMed  CAS  Google Scholar 

  3. Singer OC, Otto B, Steinmetz H, Ziemann U (2004) Acute neuropathy with multiple conduction blocks after TNFalpha monoclonal antibody therapy. Neurology 63:1754

    PubMed  Google Scholar 

  4. Cocito D, Bergamasco B, Tavella A et al (2005) Multifocal motor neuropathy during treatment with infliximab. J Peripher Nerv Syst 10:386–387

    Article  PubMed  Google Scholar 

  5. Rodriguez-Escalera C, Belzunegui J, Lopez-Dominguez L, Gonzalez C, Figueroa M (2005) Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy. Rheumatology 44:132–133

    Article  PubMed  CAS  Google Scholar 

  6. Voskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JM (1996) Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis 55:190–192

    Article  PubMed  CAS  Google Scholar 

  7. Metzler C, Arlt AC, Gross WL, Brandt J (2005) Peripheral neuropathy in patients with systemic rheumatic diseases treated with leflunomide. Ann Rheum Dis 64:1798–1800

    Article  PubMed  CAS  Google Scholar 

  8. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ (2003) Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 63:1549–1563

    Article  PubMed  CAS  Google Scholar 

  9. Chaudhry V, Corse AM, Cornblath DR et al (1994) Multifocal motor neuropathy: electrodiagnostic features. Muscle Nerve 17:198–205

    Article  PubMed  CAS  Google Scholar 

  10. Richette P, Dieude P, Damiano J, Liote F, Orcel P, Bardin T (2004) Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis. J Rheumatol 31:2079–2081

    PubMed  Google Scholar 

  11. Shakoor N, Michalska M, Harris CA, Block JA (2002) Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 359:579–580

    Article  PubMed  CAS  Google Scholar 

  12. McCain ME, Quinet RJ, Davis WE (2002) Etanercept and infliximab associated with cutaneous vasculitis. Rheumatology 41:116–117

    Article  PubMed  CAS  Google Scholar 

  13. Mohan N, Edwards E, Cupps TR et al (2004) Leukocytoclastic vasculitis associated with tumor necrosis factor-a blocking agents. J Rheumatol 31:1955–1958

    PubMed  CAS  Google Scholar 

  14. Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, Emery P (2003) Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol 30:2287–2291

    PubMed  Google Scholar 

  15. Rodino S, Sacca N, D’ Amico T, Fragomeni A, Giglio A (2003) Severe polyneuropathy complicating active Crohn’s disease: rapid response to infliximab. Gut 52:1070–1074

    Article  PubMed  CAS  Google Scholar 

  16. Armstrong DJ, McCarron MT, Wright GD (2005) Successful treatment of rheumatoid vasculitis-associated foot-drop with infliximab. J Rheumatol 32:759

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Euroclinic Hospital, 9 Athanasiadou str, 115 21, Athens, Greece

    Maria G. Tektonidou, John Serelis & Fotini N. Skopouli

Authors
  1. Maria G. Tektonidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Serelis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fotini N. Skopouli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria G. Tektonidou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tektonidou, M.G., Serelis, J. & Skopouli, F.N. Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment. Clin Rheumatol 26, 258–260 (2007). https://doi.org/10.1007/s10067-006-0317-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0317-z

Keywords

Search

Navigation